Search Results

There are 4566 results for: content related to: Peginterferon α-2a (40 kDa): an advance in the treatment of hepatitis B e antigen-positive chronic hepatitis B

  1. You have free access to this content
    Peginterferon alpha-2a versus peginterferon alpha-2b for chronic hepatitis C

    Intervention Review

    The Cochrane Library

    Goran Hauser, Tahany Awad, Kristian Thorlund, Davor Štimac, Mahasen Mabrouk and Christian Gluud

    Published Online : 28 FEB 2014, DOI: 10.1002/14651858.CD005642.pub3

  2. You have free access to this content
    Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis C

    Intervention Review

    The Cochrane Library

    Goran Hauser, Tahany Awad, Jesper Brok, Kristian Thorlund, Davor Štimac, Mahasen Mabrouk, Christian Gluud and Lise Lotte Gluud

    Published Online : 28 FEB 2014, DOI: 10.1002/14651858.CD005441.pub3

  3. You have free access to this content
    HCV Therapeutics: Approved Agents

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 1091A–1168A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26880

  4. You have free access to this content
    Peginterferon vs. standard interferon in the treatment of chronic hepatitis C

    Alimentary Pharmacology & Therapeutics

    Volume 18, Issue 7, October 2003, Pages: 661–670, A. Zaman, M. B. Fennerty and E. B. Keeffe

    Version of Record online : 19 SEP 2003, DOI: 10.1046/j.1365-2036.2003.01747.x

  5. Antiviral treatment for chronic hepatitis C in patients with human immunodeficiency virus

    Intervention Review

    The Cochrane Library

    Alfonso Iorio, Emanuela Marchesini, Tahany Awad and Lise Lotte Gluud

    Published Online : 20 JAN 2010, DOI: 10.1002/14651858.CD004888.pub2

  6. You have free access to this content
    Clinical trial: pharmacodynamics and pharmacokinetics of re-treatment with fixed-dose induction of peginterferon α-2a in hepatitis C virus genotype 1 true non-responder patients

    Alimentary Pharmacology & Therapeutics

    Volume 26, Issue 8, October 2007, Pages: 1131–1138, M. DIAGO, J. CRESPO, A. OLVEIRA, R. PÉREZ, R. BÁRCENA, J. M. SÁNCHEZ-TAPIAS, M. MUÑOZ-SÁNCHEZ and M. ROMERO-GÓMEZ

    Version of Record online : 20 AUG 2007, DOI: 10.1111/j.1365-2036.2007.03470.x

  7. You have free access to this content
    The treatment of chronic hepatitis C in HIV-infected patients: a meta-analysis

    HIV Medicine

    Volume 8, Issue 5, July 2007, Pages: 312–321, AI Kim, A Dorn, R Bouajram and S Saab

    Version of Record online : 7 JUN 2007, DOI: 10.1111/j.1468-1293.2007.00476.x

  8. You have free access to this content
    Pharmacodynamics of peginterferon alfa-2a and peginterferon alfa-2b in interferon-naïve patients with chronic hepatitis C: a randomized, controlled study

    Alimentary Pharmacology & Therapeutics

    Volume 26, Issue 3, August 2007, Pages: 369–376, R. BRUNO, P. SACCHI, C. SCAGNOLARI, F. TORRIANI, L. MAIOCCHI, S. PATRUNO, F. BELLOMI, G. FILICE and G. ANTONELLI

    Version of Record online : 29 MAY 2007, DOI: 10.1111/j.1365-2036.2007.03392.x

  9. Appropriate use of interferon for treatment of chronic hepatitis B

    Hepatology Research

    Volume 37, Issue s1, July 2007, Pages: S47–S54, Jia-Horng Kao

    Version of Record online : 9 JUL 2007, DOI: 10.1111/j.1872-034X.2007.00105.x

  10. You have free access to this content
    Systematic review: treatment of chronic hepatitis B virus infection by pegylated interferon

    Alimentary Pharmacology & Therapeutics

    Volume 22, Issue 6, September 2005, Pages: 519–528, A. Y. HUI, H. L.-Y. CHAN, A. Y.-K. CHEUNG, G. COOKSLEY and J. J.-Y. SUNG

    Version of Record online : 13 SEP 2005, DOI: 10.1111/j.1365-2036.2005.02616.x

  11. You have free access to this content
    Peginterferon alfa-2a/ribavirin in hepatitis C virus patients nontolerant or nonresponsive to peginterferon alfa-2b/ribavirin

    Alimentary Pharmacology & Therapeutics

    Volume 27, Issue 5, March 2008, Pages: 433–440, V. K. RUSTGI, S. ESPOSITO, F. M. HAMZEH and M. L. SHIFFMAN

    Version of Record online : 10 DEC 2007, DOI: 10.1111/j.1365-2036.2007.03587.x

  12. You have free access to this content
    Diagnosis, management, and treatment of hepatitis C: An update

    Hepatology

    Volume 49, Issue 4, April 2009, Pages: 1335–1374, Marc G. Ghany, Doris B. Strader, David L. Thomas and Leonard B. Seeff

    Version of Record online : 2 DEC 2008, DOI: 10.1002/hep.22759

  13. Estimating the likelihood of sustained virological response in chronic hepatitis C therapy

    Journal of Viral Hepatitis

    Volume 18, Issue 4, April 2011, Pages: e81–e90, S. Mauss, D. Hueppe, C. John, J Goelz, R. Heyne, B. Moeller, R. Link, G. Teuber, A. Herrmann, M. Spelter, S. Wollschlaeger, A. Baumgarten, K.-G. Simon, N. Dikopoulos and T. Witthoeft

    Version of Record online : 16 SEP 2010, DOI: 10.1111/j.1365-2893.2010.01372.x

  14. Extended peginterferon plus ribavirin treatment for 72 weeks versus standard peginterferon plus ribavirin treatment for 48 weeks in chronic hepatitis C genotype 1 infected slow-responder adult patients

    Intervention Review

    The Cochrane Library

    Lior H Katz, Hadar Goldvaser, Anat Gafter-Gvili and Ran Tur-Kaspa

    Published Online : 12 SEP 2012, DOI: 10.1002/14651858.CD008516.pub2

  15. Boceprevir: A Novel NS3/4 Protease Inhibitor for the Treatment of Hepatitis C

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 32, Issue 2, February 2012, Pages: 173–190, Olga M. Klibanov, Stephen B. Vickery, Jacqueline L. Olin, Lisa S. Smith and Shannon H. Williams

    Version of Record online : 30 JAN 2012, DOI: 10.1002/PHAR.1046

  16. Ribavirin in the treatment of chronic hepatitis C

    Journal of Gastroenterology and Hepatology

    Volume 23, Issue 6, June 2008, Pages: 844–855, Paul Martin and Donald M Jensen

    Version of Record online : 6 JUN 2008, DOI: 10.1111/j.1440-1746.2008.05398.x

  17. Early virologic response after peginterferon alpha-2a plus ribavirin or peginterferon alpha-2b plus ribavirin treatment in patients with chronic hepatitis C

    Journal of Viral Hepatitis

    Volume 14, Issue 10, October 2007, Pages: 721–729, A. M. Di Bisceglie, R. H. Ghalib, F. M. Hamzeh and V. K. Rustgi

    Version of Record online : 26 APR 2007, DOI: 10.1111/j.1365-2893.2007.00862.x

  18. You have free access to this content
    Improved outcomes in patients with hepatitis C with difficult-to-treat characteristics: Randomized study of higher doses of peginterferon α-2a and ribavirin

    Hepatology

    Volume 48, Issue 4, October 2008, Pages: 1033–1043, Michael W. Fried, Donald M. Jensen, Maribel Rodriguez-Torres, Lisa M. Nyberg, Adrian M. Di Bisceglie, Timothy R. Morgan, Paul J. Pockros, Amy Lin, Lisa Cupelli, Frank Duff, Ka Wang and David R. Nelson

    Version of Record online : 9 JUN 2008, DOI: 10.1002/hep.22448

  19. Twice-weekly administration of peginterferon-α-2b improves viral kinetics in patients with chronic hepatitis C genotype 1

    Journal of Viral Hepatitis

    Volume 10, Issue 4, July 2003, Pages: 271–276, E. Formann, W. Jessner, L. Bennett and P. Ferenci

    Version of Record online : 23 JUN 2003, DOI: 10.1046/j.1365-2893.2003.00446.x

  20. You have free access to this content
    Antiviral activity of telaprevir (VX-950) and peginterferon alfa-2a in patients with hepatitis C

    Hepatology

    Volume 46, Issue 3, September 2007, Pages: 640–648, Nicole Forestier, Hendrik W. Reesink, Christine J. Weegink, Lindsay McNair, Tara L. Kieffer, Hui-May Chu, Susan Purdy, Peter L.M. Jansen and Stefan Zeuzem

    Version of Record online : 24 AUG 2007, DOI: 10.1002/hep.21774